Go to:
Logótipo
Você está em: Start > Publications > View > Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review
Map of Premises
Principal
Publication

Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review

Title
Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review
Type
Another Publication in an International Scientific Journal
Year
2012
Authors
Salgado, TM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Moles, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Benrimoj, SI
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 27
Pages: 276-U336
ISSN: 0931-0509
Other information
Authenticus ID: P-002-GYJ
Abstract (EN): Background. Patients with chronic kidney disease have multiple comorbidities and require complicated therapeutic regimens. The role of pharmacists caring for these patients has been documented, but no review of the impact of these interventions has occurred to date. The aim of this work is to assess the impact of pharmacists' interventions in patients with chronic kidney disease. Methods. Medline, International Pharmaceutical Abstracts, Pharmacy Abstracts and the Cochrane Library were searched for quantitative studies addressing the contribution of pharmacists' interventions in patients with chronic kidney disease. Quality of controlled studies was assessed using the Downs and Black scale. Results. The search identified 37 studies (38 articles), involving 4743 participants, eligible for inclusion in the review. An uncontrolled design corresponded with 80% of the studies. Twenty-one articles (55.3%) reported outcome measures and process indicators, 4 (10.5%) reported only outcome measures and 13 (34.2%) reported only process indicators. Pharmacists identified 2683 drug-related problems in 1209 patients. The results from eight controlled studies (average quality score 0.57, SD = 0.10) demonstrated that pharmacists' interventions reduced all-cause hospitalisations [mean (SD) 1.8 (2.4) versus 3.1 (3.0), P = 0.02] and cumulative time hospitalised [mean (SD) 9.7 (14.7) versus 15.5 (16.3) days, P = 0.06], reduced the incidence of end-stage renal disease or death in patients with diabetic nephropathy (14.8 versus 28.2 per 100 patient-years, adjusted relative risk 60%, P < 0.001), improved management of anemia (mean 69.8 versus 43.9%, P = 0.0001 and 64.8 versus 40.4%, P = 0.043 patients on goal hemoglobin and transferrin saturation, respectively), blood pressure [systolic mean (SD) 145.3 (16.8) versus 175.8 (33.9) mmHg, P = 0.029; diastolic mean (SD) 77.0 (10.2) versus 91.8 (12.0) mmHg, P = 0.020], calcium and phosphate parameters [serum phosphate levels mean (SD) 1.81 (0.54) versus 2.07 (0.25) mmol/L, P = 0.03; calcium-phosphate product mean (SD) 4.43 (1.20) versus 4.80 (0.51) mmol(2)/L-2, P = 0.04] and lipid management [total cholesterol mean (SD) 4.4 (1.1) versus 5.0 (1.4) mmol/L, P = 0.06; low density lipoprotein cholesterol mean (SD) 2.3 (0.9) versus 2.8 (1.0) mmol/L, P = 0.013]. Results from uncontrolled studies revealed positive impact of pharmacists' interventions on reduced number of transplant rejections [mean (SD) 0.22 (0.42) versus 0.50 (0.51) episodes, P = 0.008] and adverse events (49 in 16.0% patients versus 73 in 21.3% patients, P < 0.05). Conclusions. The evidence of pharmacists' interventions in patients with chronic kidney disease is sparse, of variable quality and with heterogeneous outcomes. On the basis of best available evidence, pharmacists' interventions may have a positive impact on outcomes of patients with chronic kidney disease.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 17
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Assessing the Implementability of Clinical Pharmacist Interventions in Patients With Chronic Kidney Disease: An Analysis of Systematic Reviews (2013)
Another Publication in an International Scientific Journal
Salgado, TM; Correr, CJ; Moles, R; Benrimoj, SI; Fernandez Llimos, F
Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study (2012)
Article in International Scientific Journal
Salgado, TM; Moles, R; Benrimoj, SI; Fernandez Llimos, F
Exploring the role of pharmacists in outpatient dialysis centers: a qualitative study of nephrologist views (2013)
Article in International Scientific Journal
Salgado, TM; Moles, R; Benrimoj, SI; Fernandez Llimos, F
Designing a model to minimize inequities in hemodialysis facilities distribution (2011)
Article in International Scientific Journal
Salgado, TM; Moles, R; Benrimoj, SI; Fernandez Llimos, F
Renal nurses' views of the potential role of pharmacists in outpatient dialysis centres: A qualitative study (2014)
Article in International Conference Proceedings Book
Salgado, TM; Moles, R; Benrimoj, SI; Fernandez Llimos, F

Of the same journal

The association between TNFRSF1B rs1061624 polymorphism and hypertension in end-stage kidney disease patients on dialysis (2024)
Another Publication in an International Scientific Journal
Belo, L; Santos-Silva, A; Catarino, C; Bronze da Rocha, E
Short-term effects of gadolinium and gadoteric acid on kidney – impact on inflammation (2024)
Another Publication in an International Scientific Journal
Belo, L; Santos-Silva, A; Catarino, C; Bronze da Rocha, E
Prolonged use of an intracardiac catheter for dialysis in a patient with multiple venous access failure (2006)
Another Publication in an International Scientific Journal
Santos Araujo, C; Casanova, J; Carvalho, B; Pestana M
Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations (2009)
Another Publication in an International Scientific Journal
Oqvist, B; Brenner, BM; João Paulo Oliveira; Ortiz, A; Schaefer, R; Svarstad, E; Wanner, C; Zhang, K; Warnock, DG
MUCKLE-WELLS SYNDROME NEPHROPATHY - LACK OF RESPONSE TO COLCHICINE THERAPY (1995)
Another Publication in an International Scientific Journal
BUSTORFF, MM; João Paulo Oliveira; Carla Pinto Moura; CARVALHO, E; FARIA, V; GUERRA, L

See all (71)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-10 at 11:28:26 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book